b5media.com

Advertise with us

Enjoying this blog? Check out the rest of the Health & Wellness Channel Subscribe to this Feed

Cancer Commentary, Cancer Treatments, Cancer News, Cancer Stories, Cancer Research.

Archive for the ‘on anti-cancer ingredients’ Category

March 14th, 2008

Allergic Reaction To Cancer Drug Cetuximab (Erbitux), Found

An allergic reaction to the cancer drug cetuximab has been found.
Sometimes the reaction includes anaphylaxis, a life-threatening condition characterized by a drop in blood pressure, fainting, difficulty breathing, and wheezing.
Now researchers funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have discovered that specific pre-existing antibodies […]

By Gloria Gamat -- 2 comments

March 12th, 2008

Cancer, Nutrition, Channel Theme Day and Nutrition Month

It has all been said so many times already that one’s diet plays a big role in cancer and cancer prevention.
Although that is true, we cannot just decide one day to pick up a healthier diet (like increasing the intake of fruits and veggies!!) and be assured we won’t increase or risk of developing any […]

By Gloria Gamat -- 1 comment

March 5th, 2008

Some Vitamin Supplements May Increase Risk of Lung Cancer

According to a study of more than 77,000 vitamin users , intake of some vitamin supplements do not protect against lung cancer, especially in smokers.
Said the study’s author, Christopher G. Slatore, M.D., of the University of Washington, in Seattle:
“Our study of supplemental multivitamins, vitamin C, vitamin E and folate did not show any evidence for […]

By Gloria Gamat -- 0 comments

February 29th, 2008

Vitamin D: The New Aspirin Against Cancer?

Vitamin D has the potential to become the “new aspirin“, the little inexpensive pill that may be able to block the development of some cancers, strengthen bones, prevent multiple sclerosis and alleviate winter depression.
Such were the findings of a new Canadian study:
But it’s not science fiction. The “new aspirin” could be Vitamin D. Just as […]

By Gloria Gamat -- 0 comments

February 8th, 2008

Vaccine Booster to Resist Lung Cancer Recurrence?

That may not be unheard of according to a clinical study of a team headed by the international Ludwig Institute for Cancer Research (LICR):
What if we could prevent cancer recurrence for years after surgery by giving simple recall injections every two or three years?
…has shown that a vaccine against a protein found in cancer cells […]

By Gloria Gamat -- 3 comments

February 6th, 2008

Cervical Cancer Vaccine Trial Project Starts (?) in Uganda

Uganda is one among a few developing countries lined up to benefit from the first cervical cancer vaccine trial project to be implemented by the Programme for Appropriate Technology in Health (PATH).
PATH is a non governmental organisation hoping to come up with a cervical cancer vaccine by year 2010.
Young women in India, Peru, Uganda, and […]

By Gloria Gamat -- 3 comments

January 30th, 2008

An Aspirin a Day Keeps Colorectal Cancer Away

Before it was an aspirin a day keeps the heart doctor away.
Now, according to a study published in Gastroenterology (the official journal of the American Gastroenterological Association (AGA) Institute), the use of regular, long-term aspirin and non-steroidal anti-inflammatory drugs (NSAIDs) reduces the risk associated with colorectal cancer.
According to Andrew T. Chan, MD, MPH, Massachusetts General […]

By Gloria Gamat -- 0 comments

January 29th, 2008

Smoking, Alcohol, Caffeine and Ovarian Cancer Risk

Last week, came out interesting new findings on ovarian cancer.
New developments revealed that cigarette smoking and alcohol consumption do not have an effect on ovarian cancer risk.
However, caffeine intake may lower the risk of developing ovarian cancer, particularly in women not using hormones.
Such were the findings published in the March 1, 2008 issue of CANCER, […]

By Gloria Gamat -- 0 comments

January 25th, 2008

Cancer Drug Nexavar®, Raises Blood Pressure?

According to a study that appeared online in the January 22 issue of Lancet Oncology, patients taking Nexavar® (sorafenib) need to be carefully monitored and treated.
In clinical testing, Nexavar improved overall survival by 44 percent among people with HCC. Median overall survival was 10.7 months among those treated with the drug, versus 7.9 months among […]

By Gloria Gamat -- 0 comments

January 11th, 2008

Use of Cholesterol-Lowering Drugs May Reduce Cancer Risk

According to Wildon Farwell, M.D., of the Veterans Affairs Boston Healthcare System and colleagues, patients that are on cholesterol-lowering drugs – statins – may be at a lower risk for developing cancer — especially lung and colorectal cancers.
Statin users had a reduced risk of all cancer types compared with non-statin users. The incidence of cancer […]

By Gloria Gamat -- 0 comments